Pulmonary microRNA profiles identify involvement of Creb1 and Sec14l3 in bronchial epithelial changes in allergic

Sabine Bartel1,2, Nikola Schulz2,3, Francesca Alessandrini4

  • 1Early origins of chronic lung disease, Priority Area Asthma &Allergy, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel, Germany.

Scientific Reports
|April 7, 2017
PubMed

Insights

This study identifies novel molecular pathways in asthma pathogenesis using microRNAs (miRNAs). Researchers found that specific miRNAs target key proteins involved in allergic airway inflammation, offering new therapeutic targets for chronic asthma.

Area of Science:

  • Molecular biology
  • Immunology
  • Respiratory medicine

Background:

  • Asthma is a prevalent chronic respiratory disease with limited treatment options affecting its course.
  • Understanding early molecular events in asthma pathogenesis is crucial for developing effective therapies.
  • MicroRNAs (miRNAs) are key regulators of cellular signaling pathways with potential roles in disease development.

Purpose of the Study:

  • To identify novel asthma pathogenesis pathways using miRNAs.
  • To investigate the role of miRNA deregulation in allergic airway inflammation (AAI).
  • To validate miRNA targets in relevant asthma models and human cells.

Main Methods:

  • Assessed miRNA deregulation in mouse lungs with ovalbumin (OVA)-induced AAI.
  • Confirmed in silico predicted miRNA targets using reporter assays.
  • Validated findings in house-dust-mite (HDM)-induced AAI and human bronchial epithelial cells (NHBE).

Main Results:

  • Identified and validated Creb1 and Crtc1-3 as targets of miR-17, miR-144, and miR-21.
  • Found Sec14l3, a Creb1 target, downregulated in asthma models and IL13-treated NHBE cells.
  • Observed Sec14l3 expression correlated with ciliated cell development and inversely with goblet cell metaplasia.

Conclusions:

  • Creb1/Crtc1-3 and Sec14l3 are proposed as important in early bronchial epithelial responses to Th2 stimuli.
  • miRNA profiling can uncover novel therapeutic targets missed by mRNA-based strategies.
  • This research provides new insights into the molecular mechanisms underlying asthma.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...